hgucr

The Spanish Association of Breast Surgeons will hold its III Annual Meeting in Ciudad Real on April 25-26, 2014. The University Hospital of Ciudad Real will be the venue of the Annual Meeting, which year after year gathers the best specialists in the field of breast diseases both nationally and worldwide. The Annual Meeting will be chaired by Dr Ricardo Pardo, coordinator of the Breast Diseases Unit at the General University Hospital of Ciudad Real.

Here are some of the topics to be discussed next April during the Annual Meeting: how to approach errors and complications arising from the reconstructive surgery of breast cancer; real efficacy of early detection programs; use of oncoplastic surgery in multicentric tumors; risk factors behind poor aesthetic outcomes; indications for symmetrization; latest research in the treatment of the axilla in breast cancer; and quality control in the breast diseases unit.

One of the international speakers of this year’s annual meeting is Professor John Benson, Coordinator of the Breast Diseases Unit at Addenbrooke´s Hospital in Cambridge. He will offer an update on the management of breats cancer patients and will share the latest developments of his research.

Breast surgery

The advances achieved in the field of breast cancer have allowed for the personalization of the management of cancer patients. In the same was as personalized systemic treatments (chemotherapy or hormone therapy) or radiation therapies, breast surgery is no longer the same for all the patients diagnosed with breast cancer. Surgical treatments do not only include mastectomies or conservative surgeries, but also new techniques that allow for a better cancer treatment and an enhancement of the quality of life of the patients. The introduction of ultrasound-guided techniques has improved the achievement of negative margins in conservative surgeries.

The main goal of the Annual Meeting is to present the latest surgical techniques and the new developments that will improve the management quality of breast cancer patients.